We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Papa John's
PZZA
$806M
| $47.4M | 0.06% |
454,168
+64,694
| +17% | +$6.28M |
|
152
nLIGHT
LASR
$3.17B
| $47.4M | 0.06% |
1,305,377
+160,397
| +14% | +$4.79M |
|
153
Johnson & Johnson
JNJ
$625B
| $47.3M | 0.06% |
287,219
-24,653
| -8% | -$4.08M |
|
154
American Tower
AMT
$80.4B
| $47.1M | 0.06% |
174,227
-23,566
| -12% | -$6.01M |
|
155
NeoGenomics
NEO
$2.13B
| $46.9M | 0.06% |
1,038,795
-202,902
| -16% | -$8.99M |
|
156
Churchill Downs
CHDN
$6.12B
| $46.8M | 0.06% |
472,340
+209,702
| +80% | +$21.5M |
|
|
SWTX
157
DELISTED
SpringWorks Therapeutics
SWTX
| $46.6M | 0.06% |
565,578
-11,454
| -2% | -$870K |
|
158
Silicon Motion
SIMO
$8.68B
| $46.5M | 0.06% |
724,646
-14,779
| -2% | -$971K |
|
159
Trip.com Group
TCOM
$29.1B
| $46.4M | 0.06% |
1,307,579
+33,218
| +3% | +$1.27M |
|
160
Malibu Boats
MBUU
$567M
| $46.3M | 0.06% |
631,089
-12,834
| -2% | -$1.02M |
|
161
Procter & Gamble
PG
$339B
| $45.8M | 0.06% |
339,191
-27,350
| -7% | -$3.7M |
|
162
Morgan Stanley
MS
$340B
| $45.5M | 0.06% |
496,160
-90,347
| -15% | -$7.75M |
|
|
FOCS
163
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $45.5M | 0.06% |
937,145
-18,992
| -2% | -$916K |
|
164
Korn Ferry
KFY
$4.28B
| $45.1M | 0.05% |
621,619
+17,042
| +3% | +$1.13M |
|
165
Kadant
KAI
$3.99B
| $44.9M | 0.05% |
254,873
+386
| +0.2% | +$68K |
|
166
Mercury Systems
MRCY
$6.52B
| $44.9M | 0.05% |
677,011
-13,651
| -2% | -$943K |
|
167
Corning
GLW
$143B
| $44.7M | 0.05% |
1,093,764
-658,905
| -38% | -$28.7M |
|
168
Comcast
CMCSA
$90B
| $44.6M | 0.05% |
781,680
-60,395
| -7% | -$3.38M |
|
169
Gentherm
THRM
$1.27B
| $44.5M | 0.05% |
626,299
+83,191
| +15% | +$6.07M |
|
170
Walmart Inc
WMT
$890B
| $44.5M | 0.05% |
946,284
-60,723
| -6% | -$2.83M |
|
|
CHX
171
DELISTED
ChampionX
CHX
| $44.5M | 0.05% |
1,732,956
+279,687
| +19% | +$6.81M |
|
172
Pool Corp
POOL
$7.5B
| $44.4M | 0.05% |
96,777
+3,789
| +4% | +$1.6M |
|
173
Coca-Cola
KO
$375B
| $44.3M | 0.05% |
818,398
-45,272
| -5% | -$2.46M |
|
174
iHeartMedia
IHRT
$583M
| $44.2M | 0.05% |
1,642,427
+16,589
| +1% | +$367K |
|
175
United Parcel Service
UPS
$88.9B
| $44.2M | 0.05% |
212,353
-64,148
| -23% | -$12.8M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.